ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models
Yeom, Dong-Hoon, Lee, Yo-Seob, Ryu, Ilhwan, Lee, Sunju, Sung, Byungje, Lee, Han-Byul, Kim, Dongin, Ahn, Jin-Hyung, Ha, Eunsin, Choi, Yong-Soo, Lee, Sang Hoon, You, Weon-Kyoo
Published in International journal of molecular sciences (29.12.2020)
Published in International journal of molecular sciences (29.12.2020)
Get full text
Journal Article
Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer
Kim, Da-Hyun, Lee, Seul, Kang, Hyeok Gu, Park, Hyun-Woo, Lee, Han-Woong, Kim, Dongin, Yoem, Dong-Hoon, Ahn, Jin-Hyung, Ha, Eunsin, You, Weon-Kyoo, Lee, Sang Hoon, Kim, Seok-Jun, Chun, Kyung-Hee
Published in BMB reports (31.10.2020)
Published in BMB reports (31.10.2020)
Get full text
Journal Article
Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer
Kim, Da-Hyun, Lee, Seul, Kang, Hyeok Gu, Park, Hyun-Woo, Lee, Han-Woong, Kim, Dongin, Yoem, Dong-Hoon, Ahn, Jin-Hyung, Ha, Eunsin, You, Weon-Kyoo, Lee, Sang Hoon, Kim, Seok-Jun, Chun, Kyung-Hee
Published in BMB reports (31.10.2020)
Get full text
Published in BMB reports (31.10.2020)
Journal Article
CTX-009 (ABL001), a bispecific antibody targeting DLL4 and VEGF A, in combination with paclitaxel in patients with advanced biliary tract cancer (BTC): A phase 2 study
Oh, Do-Youn, Park, Joon Oh, Kim, Jin Won, Kim, Kyu-Pyo, Yoon, Jeesun, Kim, Tae-Yong, Kim, Seung Tae, Park, Young Suk, Lee, Jeeyun, Kim, Ji-Won, Lee, Keun-Wook, Ryoo, Baek-Yeol, Yoo, Changhoon, Hyun, BokJin, Son, HyunJoo, Kim, SunYoung, Lee, SangMi, Park, Jooyeon, Ha, Eunsin
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Abstract P02-03: Phase Ia/Ib dose-escalation study of ABL001 (CTX-009, bispecific antibody targeting DLL4 and VEGF-A) as a single agent in patients with advanced solid tumors
Lee, Jeeyun, Kim, SeungTae, Hong, JungYong, Park, YoungSuk, Park, JoonOh, Kang, WonKi, Lee, Keun-Wook, Kim, Jin Won, Kim, Ji-Won, Kim, Se Hyun, Ha, Eunsin, Lee, Sangmi, Kim, JongRan, You, Weon-Kyoo
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article
Phase 1a study results investigating the safety and preliminary efficacy of ABL001 (NOV1501), a bispecific antibody targeting VEGF and DLL4 in metastatic gastrointestinal (GI) cancer
Lee, Jeeyun, Kim, Seung, Lee, Su Jin, Park, Se Hoon, Park, Joon Oh, Ha, Eunsin, Park, Doo-Hong, Park, Neunggyu, Kim, Hoon-Kyo, Lee, Sang Hoon, You, Weon-Kyoo, Lim, Ho Yeong, Park, Young Suk, Kang, Won Ki
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)
Get full text
Patent